Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis

Clinical trial NCT05894135 · UNKNOWN

Trial details

NCT number: NCT05894135
Sponsor: Bio Genuine (Shanghai) Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Endometriosis Moderate to Severe Endometriosis-associated Pain

Start date: 2023-07-14
Primary completion: 2024-06-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.